Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NTRK3 is a receptor tyrosine kinase that binds neurotrophin-3 (NT-3) to regulate neural development, survival, and differentiation. Activation triggers downstream signaling cascades involving PLCG1, PI3K, and RAAS pathways. It plays a complex role in cancer, acting as an oncogene in some contexts and a tumor suppressor in others. Mutations and dysregulation are linked to various diseases, including neurodegenerative disorders and cancers.
Tyrosine kinase inhibition upon ligand binding
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurotrophic Receptor Tyrosine Kinase 3 (NTRK3).